L-ASPARAGINASA EFECTOS ADVERSOS PDF

0 Comments

Efectos secundarios del tratamiento para la leucemia linfoblástica aguda .. ( PEG-L asparaginasa; Oncaspar®) administrada por inyección. O Vincristina. L-asparaginase, definition: alkylating anticancer drug used in the treatment of L -asparaginasa, definition: fármaco alquilante antineoplásico, utilizado para el Los efectos secundarios más comunes son nauseas, vómitos. y otros efectos adversos de este grupo de fármacos, ya que estos pacientes los efectos citotóxicos de la quimioterapia son mediados por diversos . Actinomicina D, metotrexato, andrógenos, L-asparaginasa, procarbazina, vincristina.

Author: Shara Vuzahn
Country: Mongolia
Language: English (Spanish)
Genre: Finance
Published (Last): 14 March 2006
Pages: 147
PDF File Size: 5.41 Mb
ePub File Size: 6.97 Mb
ISBN: 610-9-95388-329-9
Downloads: 62015
Price: Free* [*Free Regsitration Required]
Uploader: Zulkigal

Known allergy to Captisol a cyclodextrin derivative used to solubilize carfilzomib; for a complete listing of Captisol-enabled drugs, see the Ligand Pharmaceuticals, Inc. A group of cancers that usually begins in the bone marrow and results in high numbers of abnormal white blood cells. EU Clinical Trials Register.

Medicinas para Quimioterapia – Nombres de Medicina

The duration of this interval must be approved by the Onyx study medical monitor. Trials with results Trials without results Clear advanced search filters.

Plans for treatment or care after the subject has ended the participation in the trial if it is different from the expected l-asparxginasa treatment of that condition. Positive culture for bacteria or fungus within 14 days of the initiation of therapy 7.

  KLOSE CLARINET PDF

Adequate liver function, defined as both of the following: For these items you should use the filters and not add them to your search terms in the text field. Both Female Only Male Only.

Definition of the end of the trial and justification where it is not the last visit of the last subject undergoing the trial.

Son aptos los sujetos que hayan sufrido una alergia previa a la asparaginasa PEG pero que puedan recibir Erwinia.

Los sujetos deben haber finalizado todo tipo de inmunoterapia activa p. For agents that have known adverse events occurring beyond 7 days after administration, this period must be extended beyond the time during which adverse events are known to occur. Subjects must have a serum creatinine level that is?

Weight Management Health Library, Free Bariatric Surgery Videos, Learn About Food, Nutrion, Diet

Date on which this record was first entered in the EudraCT database:. Active treatment for graft-versus-host disease 6. How l-asparaginasaa search [pdf]. Known allergy to any of the drugs used in the study.

Karnofsky or Lansky scores? Title of the trial for lay people, in easily understood, i. Subjects are under 18 years old.

Subjects who have had a previous allergy to PEG-asparaginase but can receive Erwinia are eligible. The IMP has been designated in this indication as an orphan drug in the Community.

Clinical trials The European L-asparagknasa Clinical Trials Register allows you to search for protocol and results information on: Phase 1b – To assess the safety and tolerability of carfilzomib, alone and in combination with induction chemotherapy, for the treatment of l-asparwginasa with relapsed or refractory acute eefctos leukemia ALL -To determine the maximum tolerated dose MTD of carfilzomib in combination with induction chemotherapy.

  DTU 64.1 PDF

Age 18 years or younger at the time of study treatment initiation. Review by the Competent Authority or Ethics Committee in the country concerned.

Committee on Advanced therapies CAT has issued a classification for this product.

Subjects must have fully recovered from the acute toxic effects of all previous chemotherapy, immunotherapy, or radiotherapy treatment before enrollment. Relapsed or Refractory Acute Lymphoblastic Leukemia. Time to toxicity will be evaluated to differentiate single-agent carfilzomib from carfilzomib in combination with induction chemotherapy? Combination product that includes a device, but does not involve an Advanced Adverrsos. Pneumonia AND sponsor name. Cancer AND drug name.

IMP with orphan designation in the indication.

Trials with results Trials without results. Restricciones de tratamientos previos: The trial involves single site in the Member State concerned. Clear advanced search filters.